Ocular Therapeutix Balance Sheet
NASDAQ: OCULHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ocular Therapeutix financial position
At the end of fiscal 2025, Ocular Therapeutix reported total assets of $808.1 million, up 76.5% from a year earlier against total liabilities of $153.7 million. Shareholders' equity stood at $654.3 million, or 81.0% of assets. The company held $737.1 million in cash and equivalents against $71.3 million of debt, a net cash position of $665.7 million.
The current ratio (current assets divided by current liabilities) was 15.39, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.11.
Summary generated from market data by MetaCap's automated system. Methodology
Ocular Therapeutix balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 737.06M | 392.10M | 195.81M | 102.30M | 164.16M | 228.06M | 54.44M | 54.06M | 41.54M | 32.94M |
| Short-Term Investments | — | — | — | — | — | — | — | — | — | 35.21M |
| Receivables | 30.65M | 32.39M | 26.18M | 21.32M | 21.14M | 12.25M | 2.55M | 201.00K | 226.00K | 250.00K |
| Inventory | 3.56M | 3.04M | 2.31M | 1.97M | 1.25M | 1.20M | 954.00K | 217.00K | 122.00K | 113.00K |
| Total Current Assets | 782.13M | 440.99M | 232.24M | 129.63M | 191.30M | 246.16M | 60.17M | 56.19M | 43.34M | 69.90M |
| Property, Plant & Equipment | 19.68M | 9.39M | 11.74M | 9.86M | 6.96M | 8.10M | 10.15M | 10.24M | 10.48M | 3.31M |
| Total Assets | 808.06M | 457.94M | 252.06M | 149.29M | 204.89M | 261.86M | 78.74M | 73.04M | 55.43M | 74.94M |
| Accounts Payable | 4.15M | 4.18M | 4.39M | 5.12M | 4.59M | 2.71M | 3.27M | 2.96M | 3.57M | 2.12M |
| Total Current Liabilities | 50.81M | 41.35M | 34.90M | 31.39M | 26.34M | 26.66M | 12.03M | 9.16M | 13.43M | 8.30M |
| Long-Term Debt | 71.34M | 68.50M | 65.79M | 25.26M | 25.00M | 16.94M | 25.01M | 24.79M | 12.47M | 14.09M |
| Total Liabilities | 153.75M | 142.59M | 160.93M | 113.91M | 116.89M | 185.77M | 82.37M | 37.17M | 29.28M | 22.93M |
| Shareholders' Equity | 654.31M | 315.34M | 91.13M | 35.38M | 88.00M | 76.09M | -3.63M | 35.88M | 26.15M | 52.01M |
| Retained Earnings | -1.16B | -891.08M | -697.58M | -616.84M | -545.80M | -539.25M | -383.62M | -297.24M | -237.26M | -173.88M |
| Total Debt | 71.34M | 68.50M | 65.79M | 25.26M | 25.00M | 16.94M | 25.01M | 24.79M | 12.47M | 14.09M |
| Net Cash (Debt) | 665.72M | 323.60M | 130.02M | 77.04M | 139.16M | 211.12M | 29.43M | 29.27M | 29.07M | 54.05M |
| Shares Outstanding | 215.93M | 157.75M | 114.96M | 77.20M | 76.73M | 76.00M | 50.33M | 41.52M | 29.66M | 25.02M |
This table shows 10 annual periods of Ocular Therapeutix's balance sheet, from FY 2025 back to FY 2016, across 16 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow OCUL's reporting calendar. What is a balance sheet?